Canrenoate potassium reduces the carvedilol initial adverse effects in patients with heart failure

Autor:	A. Schipani, M. Naldi, C. Stefanio, F. Zaca, P. Puddu, Giuseppina Santese
Rok vydání:	2000
Předmět:	medicine.medical_specialty business.industry Potassium chemistry.chemical_element medicine.disease chemistry Internal medicine Heart failure Cardiology Medicine In patient Cardiology and Cardiovascular Medicine business Adverse effect Carvedilol medicine.drug
Zdroj:	European Journal of Heart Failure. 2:97-98
ISSN:	1388-9842
DOI:	10.1016/s1388-9842(00)80347-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d4bca2ecf04396e01500872bacae0290 https://doi.org/10.1016/s1388-9842(00)80347-5 Zobrazit plný text záznamu Plný text ve formátu PDF